A valid medical license or registration certificate is required to process any claim.
Important Information for Customers in the United States:
To support regulatory compliance and promote patient safety, we would like to notify our U.S. customers about current guidance issued by the U.S. Food and Drug Administration (FDA) concerning the online purchase of injectable botulinum toxin products.
Under FDA regulations, certain prescription injectable products, including botulinum toxin, may only be supplied through authorized distribution channels. For this reason, we recommend that customers in the United States obtain these products only from licensed healthcare providers or authorized U.S. distributors who are permitted to distribute prescription medical products.
As part of our ongoing compliance efforts, we are reviewing our website, including product listings, category organization, and U.S. purchasing policies, to ensure all content and product availability remain consistent with applicable regulatory requirements. During this review, some products may be temporarily unavailable or have restricted access for customers located in the United States.
We appreciate your patience and understanding while these updates are being implemented. These measures are intended to strengthen compliance, improve transparency, and maintain the highest standards of customer safety and regulatory responsibility.
Nabota 150UI
$82.90
- Nabota 150 Units is a Hi-Pure botulinum toxin type A from Daewoong, offering an intermediate vial size between the standard 100U and 200U options. It’s the first Asian toxin approved by the FDA, EMA, and Health Canada, sold as Jeuveau in the US.
Did you like this product? Add to favorites now and follow the product.
(+82) 10 7364 7998 Send a message on WhatsApp.
Description
Nabota 150 Units — Hi-Pure Botulinum Toxin Type A
Nabota 150 Units is a botulinum toxin type A product from Daewoong Pharmaceutical Co., Ltd. in South Korea. It holds the distinction of being the first Asian botulinum toxin to earn approval from the US FDA, the European Medicines Agency, and Health Canada. In the US, Evolus markets the same formulation as Jeuveau; in Canada and the EU, distributors sell it as Nuceiva.
The 150-unit vial sits between the standard 100-unit and 200-unit sizes, giving practitioners a middle-ground option for treatment plans that don’t quite call for either standard size. Daewoong builds it on their patented Hi-Pure Technology, which achieves greater than 98.7% purity.
At a Glance
| Units per Vial | 150 units |
| Purity | Greater than 98.7% (Hi-Pure Technology) |
| Onset | Rapid, within 2–3 days |
| Duration | 3–4 months |
| Regulatory Status | FDA, EMA, and Health Canada approved |
| Manufacturer | Daewoong Pharmaceutical, South Korea |
Main Benefits
- Hi-Pure Technology: greater than 98.7% purity, removing impurities and accessory proteins to a high degree
- 900kDa biosimilar structure: closely matches Allergan’s Botox at the molecular level
- Rapid onset: patients typically see visible results within 2 to 3 days
- Intermediate vial size: flexible dosing between the standard 100U and 200U options
- Backed by large-scale trials: clinical data spans more than 2,000 patients globally
What’s Inside
| Active Ingredient | Clostridium botulinum toxin type A — 150 units |
| Stabilizer | Human Albumin — 0.75mg |
| Additive | Sodium Chloride — 1.35mg |
| Preservative | None (preservative-free) |
| Manufacturer | Daewoong Pharmaceutical, South Korea |
Mechanism of Action
Nabota blocks the release of acetylcholine at the neuromuscular junction, temporarily relaxing the targeted muscle. Hi-Pure Technology removes the majority of accessory proteins from the formulation. Because of this, less of the total injected material consists of anything beyond the active neurotoxin itself. Researchers link this lower impurity load to a reduced theoretical risk of the body developing neutralizing antibodies over repeated treatments.
Preparation & Dilution
Reconstitute the 150-unit vial with sterile, preservative-free 0.9% saline. Specifically, a standard reconstitution volume of 3.75mL produces the widely used concentration of 4 units per 0.1mL, consistent with the dilution ratios used for the 100U and 200U vials.
| Saline Added (150U vial) | Resulting Concentration |
| 1.5mL | 10 units per 0.1mL |
| 3.0mL | 5 units per 0.1mL |
| 3.75mL | 4 units per 0.1mL |
| 6.0mL | 2.5 units per 0.1mL |
Store the reconstituted solution refrigerated at 2–8°C and use it within 24 hours.
Indications
- Moderate to severe glabellar lines (frown lines)
- Crow’s feet and forehead lines
- Jawline slimming and facial contouring
- Neck bands and fine lines
- Therapeutic uses, including spasticity associated with stroke and focal hyperhidrosis, depending on local prescribing regulations
Dosage & Technique
For glabellar lines, a standard protocol uses 0.1mL per point across 5 injection points, totaling 20 units, delivered with a 30-gauge needle. The 150-unit vial offers more flexibility than the standard 100U size. Because of this, practitioners often use it for combination treatments covering multiple areas in one session. Practitioners should follow labeled recommendations for exact dosing and tailor treatment to each patient’s anatomy.
Precautions
- For use by licensed medical professionals only
- Contraindicated in patients with known hypersensitivity to any botulinum toxin preparation or formulation component
- Contraindicated in patients with neuromuscular junction disorders, such as myasthenia gravis, Lambert-Eaton syndrome, or ALS
- Contraindicated in the presence of infection at the proposed injection site
- Rare cases of distant toxin spread can occur, sometimes appearing hours to weeks after injection
Storage & Handling
- Store unopened vials refrigerated at 2–8°C
- Do not freeze
- Use within 24 hours after reconstitution, stored refrigerated
Botulinum toxin type A is a prescription medical product for use by licensed healthcare professionals only.
Frequently Asked Questions
What is Nabota 150 Units?
Nabota 150 Units is a botulinum toxin type A product from Daewoong Pharmaceutical, offering an intermediate vial size between the standard 100U and 200U options.
Is Nabota the same as Jeuveau?
Yes. Nabota is the Korean and international brand name for the formulation. Evolus markets it as Jeuveau in the United States, and distributors sell it as Nuceiva in Canada and the EU.
How long do results last?
Results generally last 3 to 4 months, varying by treatment area and individual patient factors.
Why choose the 150-unit vial over 100U or 200U?
Generally, the 150-unit size gives practitioners more flexibility for treatment plans or combination sessions that fall between the two standard vial sizes.
Buy Nabota 150 Units online from Korea Filler Experts, a trusted wholesale supplier of premium aesthetic injectables. We ship worldwide.
Copyright 2026 © Korea Filler Experts. All right reserved.
